
TruBridge Inc (TBRG) Stock Forecast & Price Target
TruBridge Inc (TBRG) Analyst Ratings
Bulls say
TruBridge Inc. has demonstrated strong financial performance, with Patient Care gross margins increasing to 59.6%, reflecting effective cost rationalization and improved non-recurring revenue. Both the Financial Health and Patient Care segments have shown organic revenue growth of 5% year-over-year, further underscored by enhanced gross margins in the Financial Health segment, which rose to 49.5% due to successful offshoring strategies. The company’s operational efficiencies and strategic client wins, particularly in the 200-400 bed market, position it for continued revenue growth, leading to an upward adjustment in revenue estimates for FY25 from $349 million to $353 million.
Bears say
The analysis highlights significant weaknesses in TruBridge Inc.'s financial performance, particularly illustrated by a 40% year-over-year decline in Financial Health bookings and over a 50% drop in Patient Care bookings. Furthermore, the company's revenue guidance for Q1 2025 is projected to be 1% below consensus estimates, indicating a concerning outlook amid declining bookings across its business segments. Despite a reduction in leverage to 3x, these underlying issues, coupled with investor fear regarding policy impacts, contribute to a negative outlook for TruBridge's stock.
This aggregate rating is based on analysts' research of TruBridge Inc and is not a guaranteed prediction by Public.com or investment advice.
TruBridge Inc (TBRG) Analyst Forecast & Price Prediction
Start investing in TruBridge Inc (TBRG)
Order type
Buy in
Order amount
Est. shares
0 shares